Document is current
Any future updates will be listed below
-
Authors
Stobart, Christopher C.
Rostad, Christina A.
Ke, Zunlong
Dillard, Rebecca S.
Hampton, Cheri M.
Strauss, Joshua D.
Yi, Hong
Hotard, Anne L.
Meng, Jia https://orcid.org/0000-0002-1504-4335
Pickles, Raymond J.
Sakamoto, Kaori
Lee, Sujin
Currier, Michael G.
Moin, Syed M.
Graham, Barney S.
Boukhvalova, Marina S.
Gilbert, Brian E.
Blanco, Jorge C. G.
Piedra, Pedro A.
Wright, Elizabeth R.
Moore, Martin L.
- License Information
-
More Information
Article History
Received: 13 April 2016
Accepted: 11 November 2016
First Online: 21 December 2016
Competing interests
: M.L.M. co-founded Meissa Vaccines, Inc. and serves as Chief Scientific Officer for the Company. M.L.M., C.C.S., A.L.H., J.M. and C.A.R. are co-inventors of RSV vaccine technology subject to evaluation in this paper. The vaccine technology has been optioned to Meissa by Emory University. The remaining authors declare no competing financial interests.
